VivoSim Labs, Inc. (VIVS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.51M
Last updated: Nov 17, 2026 at 4:10 PM ET
VivoSim Labs, Inc. (VIVS) Statistics
VivoSim Labs (VIVS) has a market cap of $2.51M. Its share count is up 531.31% from a year earlier. It holds $8.56M more cash than debt, 341.36% of its market cap.
Total Valuation
| Market Cap | $2.51M |
|---|---|
| Latest price (Nov 17, 2026) | $0.12 |
Key Dates
| Last Earnings Date | Nov 12, 2026 |
|---|---|
| Fiscal Year End | March |
Valuation Ratios
Sales and book value multiples are 14.6x and 0.3x. Its year-end P/S ranged from 4.3x to 81.1x from 2016 to 2025.
| P/S Ratio | 14.6x |
|---|---|
| P/B Ratio | 0.3x |
Price Statistics
The stock is down 94.47% over 52 weeks and trades 36.84% below its 50-day average.
| Beta (1Y) | 1.84 |
|---|---|
| 52-Week Change | -94.47% |
| 1-Month Change | -23.75% |
| 3-Month Change | -56.69% |
| 6-Month Change | -90.69% |
| 5-Year Change | -99.79% |
| 10-Year Change | -99.97% |
| Total Return (1Y) | -94.47% |
| Total Return (3Y CAGR) | -80.68% |
| Total Return (5Y CAGR) | -71.22% |
| Max Drawdown (1Y) | -95.89% |
| Max Drawdown (3Y) | -99.26% |
| Sharpe Ratio (1Y) | -2.57 |
| Correlation with SPY (1Y) | 0.22 |
| 50-Day Average | $0.19 |
| 200-Day Average | $0.96 |
| 52-Week Range | $0.12 to $3.40 |
| RSI (14 Days) | 34.0 |
| Average Volume (20 Days) | 1.22M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.50x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 3.50x |
|---|---|
| Quick Ratio | 3.49x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -141.78% and return on assets is -103.47% over the last 12 months.
| Return on Equity (ROE) | -141.78% |
|---|---|
| Return on Assets (ROA) | -103.47% |
| ROIC (5Y Average) | 138.78% |
| Inventory Turnover | 3.73x |
| Receivables Turnover | 3.18x |
| Cash Conversion Cycle | -4917 days |
Scores
VIVS has an Altman Z-Score of -52.71, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -52.71 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Balance Sheet
Shareholder equity funds 72.98% of the $9.92M in total assets.
| Cash and Equivalents | $8.56M |
|---|---|
| Total Debt | $0 |
| Net Cash | $8.56M |
| Net Cash Per Share | $0.52 |
| Working Capital | $6.71M |
| Shareholder Equity | $7.24M |
| Book Value Per Share | $0.44 |
| Total Assets | $9.92M |
| Total Liabilities | $2.68M |
Balance sheet as of Sep 30, 2026.
Dividends and Yields
VIVS does not pay a dividend.
| Buyback Yield | 32.76% |
|---|---|
| Shareholder Yield | 32.76% |
Stock Splits
The last split was a 1-for-12 reverse split on Mar 21, 2025.
| Last Split Date | Mar 21, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:12 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About VIVS
What is VIVS's market cap?
VivoSim Labs has a market cap of $2.51M.
How many shares of VIVS are outstanding?
VivoSim Labs has 16.45M shares outstanding. The count is up 531.31% from a year earlier.
Does VIVS pay a dividend?
No. VivoSim Labs does not pay a dividend.
How much debt does VIVS have?
VivoSim Labs has $0 of total debt and $8.56M of cash and equivalents, a net cash position of $8.56M.
VIVS pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors